BackApexigen Overview

Apexigen Total Liabilities

Track Apexigen's total liabilities ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$15.40M
↓ 99.68% YoYΔ $-4.81B vs prior year quarter

Peer average

Loading

Apexigen Total Liabilities History

Loading

Apexigen vs. peers: Total Liabilities Comparison

Loading

Apexigen Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Apexigen (APGN) FAQ

Apexigen posts a total liabilities of $15M as of June 2023. That compares with $4.8B in the prior-year period — down 99.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Apexigen's total liabilities was $4.8B. The latest reading is $15M — a 99.7% year-over-year decrease (period ending June 2023). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Apexigen's financial statement story. At $15M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for APGN's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Apexigen's other metric pages and overview cover the third.